Here, the targeted inhibition of miR-29 using a locked-nucleic acid strategy in a murine model of atherosclerosis (ApoE−/− mice) promoted a significant reduction in atherosclerotic lesion size and further enhanced fibrous cap thickness and plaque stability [93]. Here, APOE is linked to atherosclerosis.